Financial report interval: 2025.10.01 - 2025.12.31
Overview: Zhengye Biotechnology(ZYBT) the Revenue is 3.862 M (-38.32%);the EBIT is -2.975 M (-2944%);the EPS is -0.0726 (-2204%).